Between 2013 and 2023, Slovakia's market for opacifying preparations for X-ray and diagnostic reagents saw fluctuations, peaking at $7.08 per capita in 2013, before a general decline set in. By 2023, the value had settled to $5.92 per capita. The market experienced the highest volatility between 2014 and 2015, with significant downward adjustments. More recently, between 2021 and 2023, there was a minimal negative trend of -0.42% yearly. Over a five-year horizon ending in 2023, the market experienced a slight decrease, as reflected in the compound annual growth rate (CAGR) of approximately -0.89%.
Future trends to watch for include:
- The impact of technological advancements and innovations on product development.
- Regulatory changes affecting the availability and cost of these reagents.
- The potential influence of healthcare infrastructure developments in Slovakia.
- Shifts in healthcare funding or policy that could impact diagnostic testing demand.
| # | 24 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 South Korea | 9.87 | 2023 | View data | ||
| 2 | 2 Italy | 9.66 | 2023 | View data | ||
| 3 | 3 Greece | 8.33 | 2023 | View data | ||
| 4 | 4 Australia | 7.28 | 2023 | View data | ||
| 5 | 5 Austria | 6.83 | 2023 | View data | ||
| 6 | 6 Canada | 6.42 | 2023 | View data | ||
| 7 | 7 Slovakia | 5.92 | 2023 | |||
| 8 | 8 Spain | 5.61 | 2023 | View data | ||
| 9 | 9 Finland | 5.16 | 2023 | View data | ||
